Spero Therapeutics, Inc. (SPRO) Social Stream
SPERO THERAPEUTICS INC (SPRO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SPRO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 5 | $47 | $25 | $34.75 | $1.14 | 2948.25% |
| 2022-02-28 | 3 | $40 | $25 | $30.666 | $1.14 | 2590% |
| 2022-03-21 | 3 | $43 | $25 | $31.666 | $1.14 | 2677.72% |
| 2022-04-04 | 4 | $43 | $25 | $31.666 | $1.14 | 2677.72% |
| 2022-04-18 | 5 | $37 | $25 | $29.666 | $1.14 | 2502.28% |
| 2022-05-03 | 5 | $37 | $2 | $22 | $1.14 | 1829.82% |
| 2022-05-17 | 6 | $37 | $2 | $14.666 | $1.14 | 1186.49% |
| 2022-05-23 | 6 | $10 | $2 | $5.666 | $1.14 | 397.02% |
| 2022-08-11 | 5 | $10 | $2 | $5.666 | $1.14 | 397.02% |
| 2022-09-07 | 5 | $7 | $2 | $4.666 | $1.14 | 309.3% |
| 2022-09-23 | 5 | $8 | $5 | $6.666 | $1.14 | 484.74% |
| 2023-01-26 | 4 | $8 | $5 | $6.333 | $1.14 | 455.53% |
| 2023-04-10 | 5 | $8 | $5 | $6.333 | $1.14 | 455.53% |
| 2023-08-11 | 4 | $8 | $5 | $6.333 | $1.14 | 455.53% |
| 2023-08-14 | 4 | $8 | $5 | $6.666 | $1.14 | 484.74% |
| 2023-11-02 | 3 | $7 | $5 | $6 | $1.14 | 426.32% |
| 2023-11-14 | 3 | $7 | $7 | $7 | $1.14 | 514.04% |
The Trend in the Analyst Price Target
Over the past 42 months, SPRO's average price target has gone down $13.6.
SPRO reports an average of 354.77% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 5 | 8 | 5 | 6.333 | 1.45 | 336.76% |
| 2023-04-10 | 5 | 8 | 5 | 6.333 | 1.56 | 305.96% |
| 2023-04-10 | 4 | 8 | 5 | 6.333 | 1.56 | 305.96% |
| 2023-07-20 | 4 | 8 | 5 | 6.333 | 1.46 | 333.77% |
| 2023-08-14 | 3 | 7 | 5 | 6.000 | 1.37 | 337.96% |
SPRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
SPRO's average broker recommendation rating improved by 0.53 over the prior 18 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, SPERO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1908.91% of them.
- SPERO THERAPEUTICS INC's number of analysts covering the stock is greater than 340% of all US stocks.
- SPRO has a greater average analyst price target than 863.78% of stocks in the small market cap category.
- SPRO has a lower variance in analysts' estimates than -844.38% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, RYTM, NCNA, and KALA are the three stocks most similar to SPERO THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for SPRO? Use POWR Ratings for clearer insight into price direction.